BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31453977)

  • 21. Intraosseous lipoma. A clinical, radiologic, and pathologic study of 5 cases.
    Eyzaguirre E; Liqiang W; Karla GM; Rajendra K; Alberto A; Gatalica Z
    Ann Diagn Pathol; 2007 Oct; 11(5):320-5. PubMed ID: 17870016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hibernoma: 18F FDG PET/CT imaging.
    Subramaniam RM; Clayton AC; Karantanis D; Collins DA
    J Thorac Oncol; 2007 Jun; 2(6):569-70. PubMed ID: 17545854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric (99m)Tc-MDP uptake in mineralized tendons might mimic bone lesions: heterotopic tendon mineralization on a (99m)Tc-MDP bone scan and a (18)F-FDG PET/CT scan.
    Chen YR; Hsieh TC; Yen KY; Shen YY; Kao CH
    Clin Nucl Med; 2014 May; 39(5):480-2. PubMed ID: 23877525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J
    BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the archives of the AFIP: benign musculoskeletal lipomatous lesions.
    Murphey MD; Carroll JF; Flemming DJ; Pope TL; Gannon FH; Kransdorf MJ
    Radiographics; 2004; 24(5):1433-66. PubMed ID: 15371618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
    Garcia JR; Simo M; Perez G; Soler M; Lopez S; Setoain X; Lomeña F
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
    Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High 2-deoxy-2[F-18]fluoro-D-glucose uptake on positron emission tomography in hibernoma originally thought to be myxoid liposarcoma.
    Lin D; Jacobs M; Percy T; Dowdy Y; Mantil J
    Mol Imaging Biol; 2005; 7(3):201-2. PubMed ID: 15912423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediastinal hibernoma simulates a malignant lesion on dual time point FDG imaging.
    Burdick MJ; Jolles PR; Grimes MM; Henry DA
    Lung Cancer; 2008 Mar; 59(3):391-4. PubMed ID: 17905469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraosseous hibernoma: a case report and review of the literature.
    Yahia M; Laabidi B; M'sakni I; Bougrine F; Bouziani A
    Tunis Med; 2016 Oct; 94(8-9):622-625. PubMed ID: 28685800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hibernoma: intense uptake seen on Tc-99m tetrofosmin and FDG positron emission tomographic scanning.
    Chatterton BE; Mensforth D; Coventry BJ; Cohen P
    Clin Nucl Med; 2002 May; 27(5):369-70. PubMed ID: 11953578
    [No Abstract]   [Full Text] [Related]  

  • 37. Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
    Teke F; Teke M; Inal A; Kaplan MA; Kucukoner M; Aksu R; Urakci Z; Tasdemir B; Isikdogan A
    Asian Pac J Cancer Prev; 2015; 16(1):387-91. PubMed ID: 25640386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
    Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
    Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG PET/CT and Bone Scintigraphy in Desmoplastic Fibroma of the Bone.
    Zhang J; Nian S; Bai Y; Dong A
    Clin Nucl Med; 2022 Oct; 47(10):878-881. PubMed ID: 35426851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
    Leitha T; Cesnik R; Steiner E; Frühwald F
    Clin Nucl Med; 2004 Mar; 29(3):204-5. PubMed ID: 15162994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.